Published in TB and Outbreaks Week, May 9th, 2000
The study was reported in a recent edition of the Journal of the American Medical Association ("Rifampin and pyrazinamide vs. isoniazid for prevention of tuberculosis in HIV-infected persons - An international randomized trial," JAMA, 2000;283(11):1445-1450).
More than 1,500 HIV patients with a positive tuberculin skin test were enrolled in the study. According to F. Gordin and colleagues at the Veteran Affairs Medical Center in Washington, DC,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.